IKZF1 as a novel marker of minimal residual disease in patients with acute lymphoblastic leukaemia

被引：0
|
作者：
Barkhatov, M. [1 ]
Lebedinova, N. [1 ]
Zagrivnaya, M. [1 ]
Semenova, E. [1 ]
Zubarovskaya, L. [1 ]
Afanasyev, B. [1 ]
机构：
[1] Pavlov State Med Univ St Petersburg, St Petersburg, Russia
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S247 / S248
页数：2
相关论文
共 50 条
  • [21] Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study
    Michels, Naomi
    Boer, Judith M.
    Enshaei, Amir
    Sutton, Rosemary
    Heyman, Mats
    Ebert, Sabine
    Fiocco, Marta
    de Groot-Kruseman, Hester A.
    van der Velden, Vincent H. J.
    Barbany, Gisela
    Escherich, Gabriele
    Vora, Ajay
    Trahair, Toby
    Dalla-Pozza, Luciano
    Pieters, Rob
    zur Stadt, Udo
    Schmiegelow, Kjeld
    Moorman, Anthony, V
    Zwaan, C. Michel
    den Boer, Monique L.
    LANCET HAEMATOLOGY, 2021, 8 (10): : E700 - E710
  • [22] A NOVEL HOTSPOT FOR IKZF1 WHOLE GENE DELETIONS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
    Lopes, B. A.
    Meyer, C.
    Barbosa, T. C.
    Stadt, U. Z.
    Pombo-de-Oliveira, M. S.
    Marschalek, R.
    Emerenciano, M.
    HAEMATOLOGICA, 2015, 100 : 345 - 346
  • [23] IKZF1 in acute lymphoblastic leukemia: the rise before the fall?
    Ostergaard, Anna
    Boer, Judith M.
    van Leeuwen, Frank N.
    Pieters, Rob
    Den Boer, Monique L.
    LEUKEMIA & LYMPHOMA, 2024, 65 (14) : 2077 - 2087
  • [24] Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
    van Dongen, JJM
    Seriu, T
    Panzer-Grümayer, ER
    Biondi, A
    Pongers-Willemse, MJ
    Corral, L
    Stolz, F
    Schrappe, M
    Masera, G
    Kamps, WA
    Gadner, H
    van Wering, ER
    Ludwig, WD
    Basso, G
    de Bruijn, MAC
    Cazzaniga, G
    Hettinger, A
    van der Does-van den Berg, A
    Hop, WCJ
    Riehm, H
    Bartram, CR
    LANCET, 1998, 352 (9142): : 1731 - 1738
  • [25] Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia
    Coustan-Smith, E
    Behm, FG
    Sanchez, J
    Boyett, JM
    Hancock, ML
    Raimondi, SC
    Rubnitz, JE
    Rivera, GK
    Sandlund, JT
    Pui, CH
    Campana, D
    LANCET, 1998, 351 (9102): : 550 - 554
  • [26] Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
    Matsumura, T
    Kami, M
    Saito, T
    Sakamaki, H
    Hirai, H
    LANCET, 1999, 353 (9154): : 752 - 752
  • [27] Competitive PCR for quantification of minimal residual disease in acute lymphoblastic leukaemia
    Nyvold, C
    Madsen, HO
    Ryder, LP
    Seyfarth, J
    Engel, CA
    Svejgaard, A
    Wesenberg, F
    Schmiegelow, K
    JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 233 (1-2) : 107 - 118
  • [28] Molecular analysis of minimal residual disease in adult acute lymphoblastic leukaemia
    Foroni, L
    Hoffbrand, AV
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2002, 15 (01) : 71 - 90
  • [29] CRLF2 and IKZF1 Expression in Egyptian Acute Lymphoblastic Leukemia Patients
    Saleh, Layla
    Abd El Aziz, Sherin
    Salem, Dalia
    Eissa, Noha
    Abd El Mabood, Suzy
    Fahmi, Maryan Waheeb
    Emarah, Ziad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S165 - S165
  • [30] Outcome modeling with CRLF2, IKZF1, JAK and minimal residual disease Study in pediatric acute lymphoblastic leukemia: a Children's Oncology Group
    Chen, I. Ming
    Harvey, Richard C.
    Mullighan, Charles G.
    Gastier-Foster, Julie
    Wharton, Walker
    Kang, Huining
    Borowitz, Michael J.
    Camitta, Bruce M.
    Carroll, Andrew J.
    Devidas, Meenakshi
    Pullen, D. Jeanette
    Payne-Turner, Debbie
    Taisan, Sarah K.
    Reshmi, Shalini
    Cottrell, Catherine E.
    Reaman, Gregory H.
    Bowman, W. Paul
    Carroll, William L.
    Loh, Mignon L.
    Winick, Naomi J.
    Hunger, Stephen P.
    Willman, Cheryl L.
    BLOOD, 2012, 119 (15) : 3512 - 3522
12345